Druggio Logo

Druggio

Gilead Sciences

Gilead Sciences is a pharmaceutical company founded in 1987 and specializes in the development of therapeutics for life-threatening diseases. Its focus areas include antiviral drugs, such as those for HIV/AIDS and hepatitis, as well as treatments for other infectious diseases. Gilead Sciences has also expanded into the development of drugs for cardiovascular, respiratory, and other chronic conditions. Notable products include Truvada, Atripla, and Remdesivir.

Gilead Sciences's Drugs

Jyseleca

Approval date

2020/9/25

Veklury

Approval date

2020/5/7

Treats

Biktarvy

Approval date

2019/3/26